Two Cases of Severe Amanita Muscaria Poisoning Including a Fatality.
Ethan M Meisel, Brent Morgan, Michael A Schwartz, Ziad Kazzi, Huseyin Cetin, Aynur Sahin
Wilderness and Environmental Medicine December 1, 2022 DOI: 10.1016/j.wem.2022.06.002 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Case study Case report Peer reviewed |
|---|---|
| Sample size | 2 |
| Population | Patients who ingested Amanita muscaria mushrooms |
| Keywords | Ibotenic acid Muscimol Mushrooms Mycotoxins Toxicity |
| Key findings | Amanita muscaria ingestion can lead to serious outcomes including death, and is not always benign. |
Abstract
Ingestion of Amanita muscaria mushrooms results in transient central nervous system excitation and depression mediated by its components, ibotenic acid and muscimol. The mushroom is distributed worldwide and ingestions occur with some frequency. Although these ingestions have traditionally been considered benign, serious complications can occur. We present 2 cases of serious toxicity, including a fatality. The first case was a 44-y-old man who presented to the emergency department (ED) after cardiopulmonary arrest approximately 10 h after ingesting 4 to 5 dried A muscaria mushroom caps, which he used for their mind-altering effects. Despite successful resuscitation, he remained unresponsive and hypotensive and died 9 days later. The second case was a 75-y-old man who presented to the ED after accidentally consuming one large A muscaria mushroom cap he foraged in Eastern Turkey. The patient initially presented to the ED with hallucinations followed by lethargy, and he was intubated for airway protection. The patient's condition gradually improved, and he made a full recovery. A muscaria ingestion should not be considered benign as serious outcomes do occur. An understanding of how the main neuroactive chemicals, ibotenic acid and muscimol, affect the brain can help anticipate outcomes. Several high-risk features that portend a more serious course are identified.
Citations in the library
Cited by 13
- Reasons, Form of Ingestion and Side Effects Associated with Consumption of Amanita muscaria. Toxics April 17, 2023
- Need for a Public Health Response to the Unregulated Sales of Amanita muscaria Mushrooms American Journal of Preventive Medicine June 10, 2024
- Acute Amanita muscaria Toxicity: A Literature Review and Two Case Reports in Elderly Spouses Following Home Preparation Toxins November 25, 2025
- Psycholytic dosing or 'microdosing' of Amanita muscaria (red fly agaric) mushrooms—A retrospective case study PsyArXiv November 7, 2023
- Psychoactive mushroom edibles: trends and toxicities reported to the United States National Poison Data System®, 2023–2024 Clinical Toxicology January 6, 2026
and 8 more in the library
Cites 6
- Amanita muscaria: chemistry, biology, toxicology, and ethnomycology. Mycological research February 1, 2003
- Fly agaric (Amanita muscaria) poisoning, case report and review. Toxicon June 1, 2005
- Analysis of hallucinogenic constituents in Amanita mushrooms circulated in Japan. Forensic Science International December 20, 2006
- Toxicity of muscimol and ibotenic acid containing mushrooms reported to a regional poison control center from 2002-2016. Clinical Toxicology February 1, 2019
- Coma in the course of severe poisoning after consumption of red fly agaric (Amanita muscaria). Acta Biochimica Polonica February 1, 2016
and 1 more in the library